MAM
AGIO icon

Martingale Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Martingale Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
43,009
+7,195
+20% +$218K 0.04% 438
2026
Q1 		$1.21M Buy
+35,814
New +$1.02M 0.03% 451
2025
Q1 		– Sell
-15,520
Closed -$510K – 768
2024
Q4 		$510K Sell
15,520
-19,773
-56% -$929K 0.01% 603
2024
Q3 		$1.57M Hold
35,293
– – 0.04% 368
2024
Q2 		$1.52M Sell
35,293
-10,114
-22% -$365K 0.03% 359
2024
Q1 		$1.33M Buy
45,407
+2,097
+5% +$56.2K 0.03% 397
2023
Q4 		$965K Buy
43,310
+181
+0.4% +$4.06K 0.02% 457
2023
Q3 		$1.07M Sell
43,129
-2,291
-5% -$60.6K 0.02% 417
2023
Q2 		$1.29M Buy
45,420
+19,341
+74% +$481K 0.03% 377
2023
Q1 		$599K Buy
+26,079
New +$693K 0.01% 572
2021
Q4 		– Sell
-12,203
Closed -$564K – 819
2021
Q3 		$564K Buy
12,203
+4,999
+69% +$242K 0.01% 646
2021
Q2 		$398K Buy
+7,204
New +$403K ﹤0.01% 662

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Martingale Asset Management's AGIO Position: Q2 2026 in Review

Martingale Asset Management increased its Agios Pharmaceuticals (AGIO) stake by 20% in Q2 2026, buying an estimated $218K and bringing the position to 43,009 shares worth $1.6M. The position accounts for 0.04% of the portfolio, ranked #438.

Martingale Asset Management first reported a position in AGIO in Q2 2021 and has held it in 12 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Martingale Asset Management held 43,009 shares of Agios Pharmaceuticals worth $1.6M as of Q2 2026.
  • Martingale Asset Management bought 7,195 Agios Pharmaceuticals shares in Q2 2026, an estimated $218K.
  • Agios Pharmaceuticals made up 0.04% of Martingale Asset Management's portfolio in Q2 2026, its #438 holding.
  • Martingale Asset Management first reported a position in Agios Pharmaceuticals in Q2 2021 and has held it in 12 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.